An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels
In microvessels isolated from canine cerebral cortex, 32Pi is incorporated into phospholipids when incubated in physiological buffer containing [32Pi]orthophosphate. Norepinephrine (NE) selectively increases 32Pi incorporation into phosphatidylinositol (PI) and phosphatidic acid (PA) 60-200% over co...
Gespeichert in:
Veröffentlicht in: | Molecular pharmacology 1983-07, Vol.24 (1), p.163-167 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In microvessels isolated from canine cerebral cortex, 32Pi is incorporated into phospholipids when incubated in physiological
buffer containing [32Pi]orthophosphate. Norepinephrine (NE) selectively increases 32Pi incorporation into phosphatidylinositol
(PI) and phosphatidic acid (PA) 60-200% over control levels. Half-maximal stimulation of PI labeling is observed with 1 microM
NE, whereas maximal stimulation occurs at approximately 100 microM. Alpha 1-adrenergic agonists, phenylephrine and methoxamine,
mimic the effects of NE, whereas isoproterenol, a beta-adrenergic receptor agonist, is ineffective. A wide variety of other
agents tested had no specific effect on 32Pi incorporation into PI or PA. Prazosin, a selective alpha 1-receptor antagonist,
at a concentration of 0.05 microM inhibits 50% of the stimulation due to NE (100 microM), whereas 1 microM yohimbine, an alpha
2-selective antagonist, is required to achieve the same effect. These results demonstrate the existence of an alpha 1-adrenergic
receptor-mediated PI effect in isolated canine cerebral microvessels. |
---|---|
ISSN: | 0026-895X 1521-0111 |